首页> 外文OA文献 >Efficacy of risankizumab in patients with moderate‐to‐severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa‐1 and UltIMMa‐2 studies

【2h】

Efficacy of risankizumab in patients with moderate‐to‐severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa‐1 and UltIMMa‐2 studies

机译：Risankizumab在基线人口统计学，疾病特征和先前生物治疗患者患者中的疗效：III期Ultimma-1和Ultimma-2研究的综合分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
B. Strober; A. Menter; C. Leonardi; K. Gordon; J. Lambert; L. Puig; H. Photowala; M. Longcore; T. Zhan; P. Foley;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. 吉非替尼治疗局部晚期或转移性非小细胞肺癌患者疗效及生存的临床预测因素——两项Ⅱ期临床研究的综合分析 [J] . 赵媛媛, 张阳, 赵洪云, 癌症（英文版） . 2009,第006期
2. Impact of Prior Treatment History on Efficacy of Risankizumab Compared with Placebo in Patients with Moderate-to-Severe Plaque Psoriasis: Integrated Analyses from Three Phase 3 Trials [J] . Strober B., Lambert J., Gu Y., Experimental dermatology . 2019,第3期

机译：先前治疗史对患有中度至重度斑块牛皮癣患者的安慰剂疗效对Risankizumab的影响：三相3试验中的综合分析
3. Treatment outcomes with ixekizumab in patients with moderate‐to‐severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III III randomized studies [J] . Gottlieb A.B., Lacour J.‐P., Korman N., Journal of the European Academy of Dermatology and Venereology: JEADV . 2017,第Suppla2期

机译：治疗结果与Ixekizumab患者中度至严重的牛皮癣患者，患有或尚未接受过的生物疗法：两期III III随机研究的综合分析
4. Treatment outcomes with ixekizumab in patients with moderate-to-severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studies [J] . Gottlieb A. B., Lacour J. -P., Korman N., Journal of the European Academy of Dermatology and Venereology: JEADV . 2017,第4期

机译：治疗成果与Ixekizumab患者中度至严重的牛皮癣患者，他们已经或未接受过的生物疗法：两期III阶段随机研究的综合分析
5. Efficacy Analysis of Preservative-Free Tafluprost and Timolol in Open-Angle Glaucoma and OHT Patients in a Phase-III Study [C] . GrundenJ., Lupinacci R. International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：在第三阶段研究中，在开放角度荧光眼和OHT患者中无防腐型TaFluprost和蒂莫尔的疗效分析
6. Treatment outcomes with ixekizumab in patients with moderate‐to‐severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studies [O] . A.B. Gottlieb, J.‐P. Lacour, N. Korman, -1

机译：ixekizumab对已接受或未接受过生物疗法的中重度牛皮癣患者的治疗结果：两项三期随机研究的综合分析
7. Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis:a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies [O] . Gordon, K B, Blauvelt, A, Foley, P, 2017

机译：guselkumab在中度至重度斑块状银屑病患者亚群中的疗效：对III期VOYaGE 1和VOYaGE 2研究的汇总分析

Efficacy of risankizumab in patients with moderate‐to‐severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa‐1 and UltIMMa‐2 studies

著录项

相似文献

相关主题

期刊订阅